Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 05, 2021 07:30 ET | Source: OpGen, Inc.

OpGen Subsidiary Curetis and Annar Enter into Unyvero Distribution Partnership for Colombia

Exclusive distribution agreement for initial term of three yearsAnnar commits to minimum purchase of 10 Unyvero systems during initial term Annar to seek regulatory clearance for Unyvero products in...
December 17, 2020 08:00 ET | Source: OpGen, Inc.

Results from 1,400 Patient Sample Multicenter Study Published: Unyvero LRT BAL Panel Provides Accurate Detection in Bronchoalveolar Lavage Fluid, Allowing Enhanced Diagnosis of Lower Respiratory Tract Infections

Early diagnosis and proper choice of antimicrobials are crucial for successful management of pneumoniaStudy demonstrates Unyvero LRT BAL provides accurate detection of common agents of bacterial...
December 09, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics

Dr. Arne Materna to join Ares Genetics as new Managing Director and CEO to lead Ares into next phase of its growth Dr. Andreas Posch, while stepping down as Managing Director and CEO to pursue new...
December 01, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Group Company Ares Genetics Advances ares-genetics.cloud Platform, Presents Update at Scientific Conferences, Expects Granting of Key Patent

Extended collaboration with leading global generics company Sandoz for optimal antibiotic drug positioning by predictive antibiotic susceptibility testing Presenting study on combining...
November 24, 2020 08:00 ET | Source: OpGen, Inc.

OpGen, Inc. Announces $10 Million Private Placement Priced at the Market

GAITHERSBURG, Md., Nov. 24, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat...
November 12, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Group Company Ares Genetics Commercially Launches NGS-based Antibiotic Resistance Testing Service for Native Specimens and Receives Bulk Order from Public Health Agency

Early access program launched for the next generation of the ARESupa Universal Pathogenome Assay based on targeted next-generation sequencing (NGS) of native specimens First commercial orders...
November 11, 2020 16:05 ET | Source: OpGen, Inc.

OpGen Reports Third Quarter 2020 Financial Results and Provides Business Update

OpGen takes strategic steps to expand the Unyvero platform and product pipeline, to focus on the pending Acuitas AMR Gene Panel (isolates) FDA clearance and expects to invest significantly in...
October 29, 2020 07:30 ET | Source: OpGen, Inc.

OpGen to Provide Business Update and Financial Results for the Third Quarter 2020

GAITHERSBURG, Md., Oct. 29, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its third...
October 28, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators

Project to look at rapid molecular diagnostics for travel related and enteric diseases in small animalsVeterinary applications to be developed on Unyvero A30 RQ platformCuretis to collaborate with...
October 15, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Provides Business and Pipeline Update and Announces Preliminary Unaudited Revenue and Cash Position for the Third Quarter 2020

OpGen takes strategic steps to expand the Unyvero platform and product pipeline, to focus on the pending Acuitas AMR Gene Panel (isolates) FDA clearance and expects to invest significantly in...